Nitric oxide sustains nuclear factor kappaB activation in cytokine-stimulated chondrocytes

被引:73
作者
Clancy, RM [1 ]
Gomez, PF [1 ]
Abramson, SB [1 ]
机构
[1] NYU, Sch Med, Hosp Joint Dis, Dept Rheumatol, New York, NY 10003 USA
关键词
osteoarthritis; nitric oxide; NF-kappaB (NF-kappa B);
D O I
10.1016/j.joca.2004.04.003
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objective: In the current studies we have examined the effects of nitric oxide, and its redox derivatives peroxynitrite and S-nitrosothiol, S-nitrosocysteine, on nuclear factor kappaB (NF-kappaB) activation in cytokine-stimulated bovine chondrocytes. Methods: The kinetics of NF-kappaB activation (p65 nuclear translocation) were assessed by immunofluorescence and immunoblot assays. Results: We observed that the two nitric oxide redox species, peroxynitrite and S-nitrosocysteine, exert opposing effects on NF-kappaB activation. However, in lipopolysaccharicle (LPS)/cytokine-stimulated chondrocytes (LPS, IL-1beta and TNF-alpha (LIT)) in the presence or absence of the NOS inhibitor L-NG-monomethyl arginine citrate (L-NMMA), the results indicate that nitric oxide causes persistent activation of NF-kappaB, most likely via generation of the free radical derivative peroxynitrite. Conclusion: The studies indicate that while nitric oxide is not required for immediate NF-kappaB activation in cytokine-stimulated chondrocytes, its effect is to sustain nuclear translocation of p65 and thereby provide a persistent "on signal" to NF-kappaB dependent gene transcription. Persistent activation of NF-kappaB may represent a mechanism by which nitric oxide sustains catabolic processes and promotes cartilage degeneration in osteoarthritis. (C) 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:552 / 558
页数:7
相关论文
共 26 条
  • [1] Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage - Influence of nitric oxide
    Amin, AR
    Attur, M
    Patel, RN
    Thakker, GD
    Marshall, PJ
    Rediske, J
    Stuchin, SA
    Patel, IR
    Abramson, SB
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (06) : 1231 - 1237
  • [2] Beauparlant Pierre, 1996, Cytokine and Growth Factor Reviews, V7, P175, DOI 10.1016/1359-6101(96)00020-2
  • [3] The role of nuclear factor-kappa B in cytokine gene regulation
    Blackwell, TS
    Christman, JW
    [J]. AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1997, 17 (01) : 3 - 9
  • [4] Nitric oxide synthase/COX cross-talk: Nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production
    Clancy, R
    Varenika, B
    Huang, WQ
    Ballou, L
    Attur, M
    Amin, AR
    Abramson, SB
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (03) : 1582 - 1587
  • [5] Activation of stress-activated protein kinase in osteoarthritic cartilage: evidence for nitric oxide dependence
    Clancy, R
    Rediske, J
    Koehne, C
    Stoyanovsky, D
    Amin, A
    Attur, M
    Iyama, K
    Abramson, SB
    [J]. OSTEOARTHRITIS AND CARTILAGE, 2001, 9 (04) : 294 - 299
  • [6] Preparation and properties of S-nitroso-L-cysteine ethyl ester, an intracellular nitrosating agent
    Clancy, R
    Cederbaum, AI
    Stoyanovsky, DA
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (12) : 2035 - 2038
  • [7] Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO
  • [8] 2-S
  • [9] Clancy RM, 1997, J CELL PHYSIOL, V172, P183, DOI 10.1002/(SICI)1097-4652(199708)172:2<183::AID-JCP5>3.0.CO
  • [10] 2-K